Earnings call transcript: NEXT Biometrics reports Q2 2025 revenue decline

NEXT Biometrics reported a challenging Q2 2025, with negative reported revenue of -$2.2 million and a cash position decline to $22.1 million, largely due to China-related irregularities and an India market pause that also compressed gross margins to 39%. Despite these financial headwinds and an InvestingPro assessment of being overvalued, the company's stock delivered a 102% return over the past year. Management remains optimistic, citing new product launches like the NeXT Granite sensor, securing its first mass production order for the Fab 30 ($3.2M), and a major IAM solution order. The company anticipates achieving cash positivity by Q4 2025 and projects a return to predictable quarterly revenues of NOK 25-30 million, targeting NOK 50 million by 2026, driven by product innovation and strategic market expansion.

Analysis

NEXT Biometrics (NEXT) presented a dichotomous Q2 2025, marked by severe financial distress juxtaposed with strong operational progress and optimistic forward guidance. Financially, the company is under significant pressure, reporting negative revenue of -$2.2 million due to accounting irregularities and restatements in its China business, which necessitated taking back goods for resale. This, combined with a market pause in India, contributed to an adjusted EBITDA loss of -$14.2 million and a sharp decline in the cash position to $22.1 million from $39.9 million in the prior quarter, prompting a private placement to solve near-term liquidity needs. Gross margins also compressed significantly to 39% from 57% a year prior due to an unfavorable product mix. In stark contrast to these results, the company has achieved key strategic milestones, including the launch of its new NeXT Granite (Fab 30) sensor and securing a crucial $3.2 million mass production order for it. Furthermore, NEXT has already achieved its full-year target of 12 design wins in the first six months and secured a notable IAM order. Management is guiding for a return to cash-flow positivity by Q4 2025 and a target quarterly revenue of NOK 50 million by 2026, creating a high-stakes scenario where the investment thesis hinges entirely on execution against this optimistic pipeline and overcoming current operational and liquidity challenges.

Key Decisions for Investors

• Investors must weigh the significant execution risk, underscored by negative Q2 revenue and severe cash burn, against the high-growth potential demonstrated by new product launches and a strong order pipeline.
• Closely monitor the company's ability to secure its proposed private placement to bridge its liquidity gap and achieve its guidance of cash-flow positivity by Q4 2025, as failure to meet these milestones would be a major red flag.
• Given the stock's 102% return over the past year and an external analysis suggesting it is overvalued, consider that much of the future optimism may already be priced in, requiring near-perfect execution to justify the current valuation.
• Track the progress of the China business restructuring and the revenue recovery from the Indian market, as these are the primary drivers of the recent poor performance and key to achieving normalized quarterly revenues.